nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2D6—Hydroxyurea—head and neck cancer	0.173	0.254	CbGbCtD
Propafenone—CYP2C8—Fluorouracil—head and neck cancer	0.103	0.152	CbGbCtD
Propafenone—CYP1A2—Fluorouracil—head and neck cancer	0.0801	0.118	CbGbCtD
Propafenone—CYP2C9—Fluorouracil—head and neck cancer	0.0722	0.106	CbGbCtD
Propafenone—ABCB1—Vinblastine—head and neck cancer	0.0649	0.0956	CbGbCtD
Propafenone—CYP2D6—Vinblastine—head and neck cancer	0.0612	0.09	CbGbCtD
Propafenone—ABCB1—Docetaxel—head and neck cancer	0.0535	0.0788	CbGbCtD
Propafenone—CYP3A4—Vinblastine—head and neck cancer	0.0389	0.0573	CbGbCtD
Propafenone—CYP3A4—Docetaxel—head and neck cancer	0.0321	0.0472	CbGbCtD
Propafenone—Carvedilol—VEGFA—head and neck cancer	0.00236	0.341	CrCbGaD
Propafenone—Oesophagitis—Fluorouracil—head and neck cancer	0.00153	0.00531	CcSEcCtD
Propafenone—Breast disorder—Hydroxyurea—head and neck cancer	0.00152	0.00529	CcSEcCtD
Propafenone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00143	0.00496	CcSEcCtD
Propafenone—Depression—Vinblastine—head and neck cancer	0.00142	0.00494	CcSEcCtD
Propafenone—Eye irritation—Docetaxel—head and neck cancer	0.00141	0.00491	CcSEcCtD
Propafenone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0014	0.00485	CcSEcCtD
Propafenone—Dysuria—Hydroxyurea—head and neck cancer	0.00136	0.00473	CcSEcCtD
Propafenone—Bone disorder—Docetaxel—head and neck cancer	0.00133	0.00464	CcSEcCtD
Propafenone—Agranulocytosis—Vinblastine—head and neck cancer	0.00133	0.00462	CcSEcCtD
Propafenone—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00133	0.00461	CcSEcCtD
Propafenone—Weight increased—Hydroxyurea—head and neck cancer	0.00132	0.00461	CcSEcCtD
Propafenone—Oliguria—Docetaxel—head and neck cancer	0.00131	0.00455	CcSEcCtD
Propafenone—Infestation—Hydroxyurea—head and neck cancer	0.0013	0.00451	CcSEcCtD
Propafenone—Infestation NOS—Hydroxyurea—head and neck cancer	0.0013	0.00451	CcSEcCtD
Propafenone—Drowsiness—Hydroxyurea—head and neck cancer	0.0013	0.00451	CcSEcCtD
Propafenone—Amnesia—Fluorouracil—head and neck cancer	0.00129	0.00449	CcSEcCtD
Propafenone—Haemoglobin—Vinblastine—head and neck cancer	0.00128	0.00447	CcSEcCtD
Propafenone—Salsalate—PTGS2—head and neck cancer	0.00128	0.185	CrCbGaD
Propafenone—Oxaprozin—PTGS2—head and neck cancer	0.00128	0.185	CrCbGaD
Propafenone—Haemorrhage—Vinblastine—head and neck cancer	0.00128	0.00444	CcSEcCtD
Propafenone—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00127	0.00443	CcSEcCtD
Propafenone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00127	0.00443	CcSEcCtD
Propafenone—Hypoaesthesia—Vinblastine—head and neck cancer	0.00127	0.00442	CcSEcCtD
Propafenone—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00127	0.00441	CcSEcCtD
Propafenone—Hearing impaired—Docetaxel—head and neck cancer	0.00127	0.0044	CcSEcCtD
Propafenone—Stomatitis—Hydroxyurea—head and neck cancer	0.00127	0.0044	CcSEcCtD
Propafenone—Cardiac failure—Fluorouracil—head and neck cancer	0.00124	0.00432	CcSEcCtD
Propafenone—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00123	0.00427	CcSEcCtD
Propafenone—Respiratory failure—Docetaxel—head and neck cancer	0.00123	0.00427	CcSEcCtD
Propafenone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00121	0.00422	CcSEcCtD
Propafenone—Hepatocellular injury—Docetaxel—head and neck cancer	0.00121	0.00419	CcSEcCtD
Propafenone—Blood pressure increased—Docetaxel—head and neck cancer	0.00121	0.00419	CcSEcCtD
Propafenone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00117	0.00407	CcSEcCtD
Propafenone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00117	0.00405	CcSEcCtD
Propafenone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00115	0.00401	CcSEcCtD
Propafenone—Carvedilol—CYP1A1—head and neck cancer	0.00114	0.164	CrCbGaD
Propafenone—Ataxia—Fluorouracil—head and neck cancer	0.00114	0.00397	CcSEcCtD
Propafenone—Alopecia—Vinblastine—head and neck cancer	0.00113	0.00393	CcSEcCtD
Propafenone—Dry skin—Fluorouracil—head and neck cancer	0.00111	0.00387	CcSEcCtD
Propafenone—Oesophagitis—Docetaxel—head and neck cancer	0.0011	0.00383	CcSEcCtD
Propafenone—Muscular weakness—Fluorouracil—head and neck cancer	0.00107	0.00372	CcSEcCtD
Propafenone—Angiopathy—Hydroxyurea—head and neck cancer	0.00106	0.00368	CcSEcCtD
Propafenone—Dysphagia—Fluorouracil—head and neck cancer	0.00105	0.00364	CcSEcCtD
Propafenone—Eosinophilia—Fluorouracil—head and neck cancer	0.00104	0.00361	CcSEcCtD
Propafenone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00103	0.00359	CcSEcCtD
Propafenone—Alopecia—Hydroxyurea—head and neck cancer	0.00103	0.00358	CcSEcCtD
Propafenone—Anaemia—Vinblastine—head and neck cancer	0.00103	0.00358	CcSEcCtD
Propafenone—Angina pectoris—Fluorouracil—head and neck cancer	0.00102	0.00355	CcSEcCtD
Propafenone—Erythema—Hydroxyurea—head and neck cancer	0.00101	0.00353	CcSEcCtD
Propafenone—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00101	0.0035	CcSEcCtD
Propafenone—Malaise—Vinblastine—head and neck cancer	0.001	0.00349	CcSEcCtD
Propafenone—Vertigo—Vinblastine—head and neck cancer	0.000999	0.00348	CcSEcCtD
Propafenone—Leukopenia—Vinblastine—head and neck cancer	0.000996	0.00346	CcSEcCtD
Propafenone—Deafness—Docetaxel—head and neck cancer	0.000978	0.0034	CcSEcCtD
Propafenone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000974	0.00339	CcSEcCtD
Propafenone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000965	0.00336	CcSEcCtD
Propafenone—Convulsion—Vinblastine—head and neck cancer	0.000964	0.00335	CcSEcCtD
Propafenone—Hypertension—Vinblastine—head and neck cancer	0.00096	0.00334	CcSEcCtD
Propafenone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000941	0.00327	CcSEcCtD
Propafenone—Anaemia—Hydroxyurea—head and neck cancer	0.000937	0.00326	CcSEcCtD
Propafenone—Discomfort—Vinblastine—head and neck cancer	0.000936	0.00325	CcSEcCtD
Propafenone—Hot flush—Docetaxel—head and neck cancer	0.000935	0.00325	CcSEcCtD
Propafenone—Infestation NOS—Fluorouracil—head and neck cancer	0.000934	0.00325	CcSEcCtD
Propafenone—Infestation—Fluorouracil—head and neck cancer	0.000934	0.00325	CcSEcCtD
Propafenone—Menopausal symptoms—Docetaxel—head and neck cancer	0.000927	0.00323	CcSEcCtD
Propafenone—Atrial fibrillation—Docetaxel—head and neck cancer	0.000923	0.00321	CcSEcCtD
Propafenone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000916	0.00319	CcSEcCtD
Propafenone—Dermatitis bullous—Docetaxel—head and neck cancer	0.000915	0.00318	CcSEcCtD
Propafenone—Malaise—Hydroxyurea—head and neck cancer	0.000915	0.00318	CcSEcCtD
Propafenone—Stomatitis—Fluorouracil—head and neck cancer	0.000911	0.00317	CcSEcCtD
Propafenone—Leukopenia—Hydroxyurea—head and neck cancer	0.000908	0.00316	CcSEcCtD
Propafenone—Cardiac failure—Docetaxel—head and neck cancer	0.000897	0.00312	CcSEcCtD
Propafenone—Thrombocytopenia—Vinblastine—head and neck cancer	0.000889	0.00309	CcSEcCtD
Propafenone—Epistaxis—Fluorouracil—head and neck cancer	0.000881	0.00307	CcSEcCtD
Propafenone—Convulsion—Hydroxyurea—head and neck cancer	0.000879	0.00306	CcSEcCtD
Propafenone—Hyponatraemia—Docetaxel—head and neck cancer	0.000879	0.00306	CcSEcCtD
Propafenone—Agranulocytosis—Fluorouracil—head and neck cancer	0.000872	0.00303	CcSEcCtD
Propafenone—Propranolol—CYP1A1—head and neck cancer	0.000867	0.125	CrCbGaD
Propafenone—Anorexia—Vinblastine—head and neck cancer	0.000865	0.00301	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000858	0.00298	CcSEcCtD
Propafenone—Discomfort—Hydroxyurea—head and neck cancer	0.000853	0.00297	CcSEcCtD
Propafenone—Haemoglobin—Fluorouracil—head and neck cancer	0.000843	0.00293	CcSEcCtD
Propafenone—Rhinitis—Fluorouracil—head and neck cancer	0.000841	0.00292	CcSEcCtD
Propafenone—Haemorrhage—Fluorouracil—head and neck cancer	0.000839	0.00292	CcSEcCtD
Propafenone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000834	0.0029	CcSEcCtD
Propafenone—Oedema—Hydroxyurea—head and neck cancer	0.000828	0.00288	CcSEcCtD
Propafenone—Ataxia—Docetaxel—head and neck cancer	0.000823	0.00286	CcSEcCtD
Propafenone—Infection—Hydroxyurea—head and neck cancer	0.000822	0.00286	CcSEcCtD
Propafenone—Paraesthesia—Vinblastine—head and neck cancer	0.000815	0.00284	CcSEcCtD
Propafenone—Dehydration—Docetaxel—head and neck cancer	0.000814	0.00283	CcSEcCtD
Propafenone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000812	0.00282	CcSEcCtD
Propafenone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00081	0.00282	CcSEcCtD
Propafenone—Liver function test abnormal—Docetaxel—head and neck cancer	0.000808	0.00281	CcSEcCtD
Propafenone—Skin disorder—Hydroxyurea—head and neck cancer	0.000804	0.0028	CcSEcCtD
Propafenone—Dry skin—Docetaxel—head and neck cancer	0.000802	0.00279	CcSEcCtD
Propafenone—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000799	0.00278	CcSEcCtD
Propafenone—Breast disorder—Docetaxel—head and neck cancer	0.000791	0.00275	CcSEcCtD
Propafenone—Anorexia—Hydroxyurea—head and neck cancer	0.000789	0.00274	CcSEcCtD
Propafenone—Decreased appetite—Vinblastine—head and neck cancer	0.000789	0.00274	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000788	0.00274	CcSEcCtD
Propafenone—Cramp muscle—Docetaxel—head and neck cancer	0.000788	0.00274	CcSEcCtD
Propafenone—Pain—Vinblastine—head and neck cancer	0.000776	0.0027	CcSEcCtD
Propafenone—Constipation—Vinblastine—head and neck cancer	0.000776	0.0027	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000772	0.00268	CcSEcCtD
Propafenone—Dysphagia—Docetaxel—head and neck cancer	0.000756	0.00263	CcSEcCtD
Propafenone—Arrhythmia—Fluorouracil—head and neck cancer	0.000749	0.00261	CcSEcCtD
Propafenone—Feeling abnormal—Vinblastine—head and neck cancer	0.000748	0.0026	CcSEcCtD
Propafenone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000742	0.00258	CcSEcCtD
Propafenone—Alopecia—Fluorouracil—head and neck cancer	0.000741	0.00258	CcSEcCtD
Propafenone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000738	0.00257	CcSEcCtD
Propafenone—Angina pectoris—Docetaxel—head and neck cancer	0.000737	0.00256	CcSEcCtD
Propafenone—Somnolence—Hydroxyurea—head and neck cancer	0.000736	0.00256	CcSEcCtD
Propafenone—Erythema—Fluorouracil—head and neck cancer	0.00073	0.00254	CcSEcCtD
Propafenone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000729	0.00253	CcSEcCtD
Propafenone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00072	0.0025	CcSEcCtD
Propafenone—Abdominal pain—Vinblastine—head and neck cancer	0.000718	0.0025	CcSEcCtD
Propafenone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000715	0.00249	CcSEcCtD
Propafenone—Fatigue—Hydroxyurea—head and neck cancer	0.000714	0.00248	CcSEcCtD
Propafenone—Pain—Hydroxyurea—head and neck cancer	0.000708	0.00246	CcSEcCtD
Propafenone—Constipation—Hydroxyurea—head and neck cancer	0.000708	0.00246	CcSEcCtD
Propafenone—Weight increased—Docetaxel—head and neck cancer	0.000688	0.00239	CcSEcCtD
Propafenone—Vision blurred—Fluorouracil—head and neck cancer	0.000688	0.00239	CcSEcCtD
Propafenone—Weight decreased—Docetaxel—head and neck cancer	0.000684	0.00238	CcSEcCtD
Propafenone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000682	0.00237	CcSEcCtD
Propafenone—Anaemia—Fluorouracil—head and neck cancer	0.000675	0.00235	CcSEcCtD
Propafenone—Infestation—Docetaxel—head and neck cancer	0.000674	0.00235	CcSEcCtD
Propafenone—Infestation NOS—Docetaxel—head and neck cancer	0.000674	0.00235	CcSEcCtD
Propafenone—Hypersensitivity—Vinblastine—head and neck cancer	0.000669	0.00233	CcSEcCtD
Propafenone—Renal failure—Docetaxel—head and neck cancer	0.000663	0.00231	CcSEcCtD
Propafenone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000661	0.0023	CcSEcCtD
Propafenone—Stomatitis—Docetaxel—head and neck cancer	0.000657	0.00229	CcSEcCtD
Propafenone—Jaundice—Docetaxel—head and neck cancer	0.000657	0.00229	CcSEcCtD
Propafenone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000654	0.00228	CcSEcCtD
Propafenone—Leukopenia—Fluorouracil—head and neck cancer	0.000653	0.00227	CcSEcCtD
Propafenone—Asthenia—Vinblastine—head and neck cancer	0.000651	0.00227	CcSEcCtD
Propafenone—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000638	0.00222	CcSEcCtD
Propafenone—Epistaxis—Docetaxel—head and neck cancer	0.000636	0.00221	CcSEcCtD
Propafenone—Convulsion—Fluorouracil—head and neck cancer	0.000633	0.0022	CcSEcCtD
Propafenone—Agranulocytosis—Docetaxel—head and neck cancer	0.000629	0.00219	CcSEcCtD
Propafenone—Chest pain—Fluorouracil—head and neck cancer	0.000622	0.00216	CcSEcCtD
Propafenone—Myalgia—Fluorouracil—head and neck cancer	0.000622	0.00216	CcSEcCtD
Propafenone—Diarrhoea—Vinblastine—head and neck cancer	0.000621	0.00216	CcSEcCtD
Propafenone—Discomfort—Fluorouracil—head and neck cancer	0.000614	0.00214	CcSEcCtD
Propafenone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00061	0.00212	CcSEcCtD
Propafenone—Haemoglobin—Docetaxel—head and neck cancer	0.000608	0.00212	CcSEcCtD
Propafenone—Rhinitis—Docetaxel—head and neck cancer	0.000607	0.00211	CcSEcCtD
Propafenone—Haemorrhage—Docetaxel—head and neck cancer	0.000605	0.00211	CcSEcCtD
Propafenone—Hepatitis—Docetaxel—head and neck cancer	0.000605	0.00211	CcSEcCtD
Propafenone—Hypoaesthesia—Docetaxel—head and neck cancer	0.000602	0.00209	CcSEcCtD
Propafenone—Confusional state—Fluorouracil—head and neck cancer	0.000601	0.00209	CcSEcCtD
Propafenone—Dizziness—Vinblastine—head and neck cancer	0.0006	0.00209	CcSEcCtD
Propafenone—Urinary tract disorder—Docetaxel—head and neck cancer	0.000598	0.00208	CcSEcCtD
Propafenone—Oedema—Fluorouracil—head and neck cancer	0.000596	0.00207	CcSEcCtD
Propafenone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000595	0.00207	CcSEcCtD
Propafenone—Asthenia—Hydroxyurea—head and neck cancer	0.000594	0.00207	CcSEcCtD
Propafenone—Urethral disorder—Docetaxel—head and neck cancer	0.000593	0.00206	CcSEcCtD
Propafenone—Infection—Fluorouracil—head and neck cancer	0.000592	0.00206	CcSEcCtD
Propafenone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000584	0.00203	CcSEcCtD
Propafenone—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000583	0.00203	CcSEcCtD
Propafenone—Visual impairment—Docetaxel—head and neck cancer	0.000583	0.00203	CcSEcCtD
Propafenone—Tachycardia—Fluorouracil—head and neck cancer	0.000582	0.00202	CcSEcCtD
Propafenone—Vomiting—Vinblastine—head and neck cancer	0.000577	0.00201	CcSEcCtD
Propafenone—Headache—Vinblastine—head and neck cancer	0.000569	0.00198	CcSEcCtD
Propafenone—Anorexia—Fluorouracil—head and neck cancer	0.000568	0.00198	CcSEcCtD
Propafenone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000566	0.00197	CcSEcCtD
Propafenone—Eye disorder—Docetaxel—head and neck cancer	0.000566	0.00197	CcSEcCtD
Propafenone—Cardiac disorder—Docetaxel—head and neck cancer	0.000562	0.00195	CcSEcCtD
Propafenone—Flushing—Docetaxel—head and neck cancer	0.000562	0.00195	CcSEcCtD
Propafenone—Hypotension—Fluorouracil—head and neck cancer	0.000557	0.00194	CcSEcCtD
Propafenone—Angiopathy—Docetaxel—head and neck cancer	0.000549	0.00191	CcSEcCtD
Propafenone—Dizziness—Hydroxyurea—head and neck cancer	0.000547	0.0019	CcSEcCtD
Propafenone—Immune system disorder—Docetaxel—head and neck cancer	0.000547	0.0019	CcSEcCtD
Propafenone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000546	0.0019	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000543	0.00189	CcSEcCtD
Propafenone—Arrhythmia—Docetaxel—head and neck cancer	0.000541	0.00188	CcSEcCtD
Propafenone—Nausea—Vinblastine—head and neck cancer	0.000539	0.00188	CcSEcCtD
Propafenone—Insomnia—Fluorouracil—head and neck cancer	0.000539	0.00187	CcSEcCtD
Propafenone—Paraesthesia—Fluorouracil—head and neck cancer	0.000535	0.00186	CcSEcCtD
Propafenone—Alopecia—Docetaxel—head and neck cancer	0.000535	0.00186	CcSEcCtD
Propafenone—Dyspnoea—Fluorouracil—head and neck cancer	0.000531	0.00185	CcSEcCtD
Propafenone—Mental disorder—Docetaxel—head and neck cancer	0.00053	0.00184	CcSEcCtD
Propafenone—Somnolence—Fluorouracil—head and neck cancer	0.00053	0.00184	CcSEcCtD
Propafenone—Erythema—Docetaxel—head and neck cancer	0.000527	0.00183	CcSEcCtD
Propafenone—Malnutrition—Docetaxel—head and neck cancer	0.000527	0.00183	CcSEcCtD
Propafenone—Vomiting—Hydroxyurea—head and neck cancer	0.000526	0.00183	CcSEcCtD
Propafenone—Dyspepsia—Fluorouracil—head and neck cancer	0.000524	0.00182	CcSEcCtD
Propafenone—Rash—Hydroxyurea—head and neck cancer	0.000522	0.00182	CcSEcCtD
Propafenone—Dermatitis—Hydroxyurea—head and neck cancer	0.000521	0.00181	CcSEcCtD
Propafenone—Headache—Hydroxyurea—head and neck cancer	0.000519	0.0018	CcSEcCtD
Propafenone—Decreased appetite—Fluorouracil—head and neck cancer	0.000518	0.0018	CcSEcCtD
Propafenone—Dysgeusia—Docetaxel—head and neck cancer	0.000516	0.00179	CcSEcCtD
Propafenone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000514	0.00179	CcSEcCtD
Propafenone—Pain—Fluorouracil—head and neck cancer	0.00051	0.00177	CcSEcCtD
Propafenone—Muscle spasms—Docetaxel—head and neck cancer	0.000507	0.00176	CcSEcCtD
Propafenone—Nausea—Hydroxyurea—head and neck cancer	0.000492	0.00171	CcSEcCtD
Propafenone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000491	0.00171	CcSEcCtD
Propafenone—Anaemia—Docetaxel—head and neck cancer	0.000487	0.00169	CcSEcCtD
Propafenone—Urticaria—Fluorouracil—head and neck cancer	0.000473	0.00165	CcSEcCtD
Propafenone—Syncope—Docetaxel—head and neck cancer	0.000473	0.00164	CcSEcCtD
Propafenone—Leukopenia—Docetaxel—head and neck cancer	0.000472	0.00164	CcSEcCtD
Propafenone—Body temperature increased—Fluorouracil—head and neck cancer	0.000471	0.00164	CcSEcCtD
Propafenone—Palpitations—Docetaxel—head and neck cancer	0.000466	0.00162	CcSEcCtD
Propafenone—Loss of consciousness—Docetaxel—head and neck cancer	0.000463	0.00161	CcSEcCtD
Propafenone—Cough—Docetaxel—head and neck cancer	0.00046	0.0016	CcSEcCtD
Propafenone—Convulsion—Docetaxel—head and neck cancer	0.000457	0.00159	CcSEcCtD
Propafenone—Hypertension—Docetaxel—head and neck cancer	0.000455	0.00158	CcSEcCtD
Propafenone—Chest pain—Docetaxel—head and neck cancer	0.000449	0.00156	CcSEcCtD
Propafenone—Myalgia—Docetaxel—head and neck cancer	0.000449	0.00156	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000446	0.00155	CcSEcCtD
Propafenone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000439	0.00153	CcSEcCtD
Propafenone—Dry mouth—Docetaxel—head and neck cancer	0.000439	0.00153	CcSEcCtD
Propafenone—Confusional state—Docetaxel—head and neck cancer	0.000434	0.00151	CcSEcCtD
Propafenone—Oedema—Docetaxel—head and neck cancer	0.00043	0.0015	CcSEcCtD
Propafenone—Infection—Docetaxel—head and neck cancer	0.000427	0.00149	CcSEcCtD
Propafenone—Shock—Docetaxel—head and neck cancer	0.000423	0.00147	CcSEcCtD
Propafenone—Nervous system disorder—Docetaxel—head and neck cancer	0.000422	0.00147	CcSEcCtD
Propafenone—Pruritus—Fluorouracil—head and neck cancer	0.000422	0.00147	CcSEcCtD
Propafenone—Thrombocytopenia—Docetaxel—head and neck cancer	0.000421	0.00146	CcSEcCtD
Propafenone—Tachycardia—Docetaxel—head and neck cancer	0.00042	0.00146	CcSEcCtD
Propafenone—Skin disorder—Docetaxel—head and neck cancer	0.000418	0.00145	CcSEcCtD
Propafenone—Anorexia—Docetaxel—head and neck cancer	0.00041	0.00143	CcSEcCtD
Propafenone—Diarrhoea—Fluorouracil—head and neck cancer	0.000408	0.00142	CcSEcCtD
Propafenone—Hypotension—Docetaxel—head and neck cancer	0.000402	0.0014	CcSEcCtD
Propafenone—Dizziness—Fluorouracil—head and neck cancer	0.000394	0.00137	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000392	0.00136	CcSEcCtD
Propafenone—Insomnia—Docetaxel—head and neck cancer	0.000389	0.00135	CcSEcCtD
Propafenone—Paraesthesia—Docetaxel—head and neck cancer	0.000386	0.00134	CcSEcCtD
Propafenone—Dyspnoea—Docetaxel—head and neck cancer	0.000383	0.00133	CcSEcCtD
Propafenone—Somnolence—Docetaxel—head and neck cancer	0.000382	0.00133	CcSEcCtD
Propafenone—Vomiting—Fluorouracil—head and neck cancer	0.000379	0.00132	CcSEcCtD
Propafenone—Dyspepsia—Docetaxel—head and neck cancer	0.000379	0.00132	CcSEcCtD
Propafenone—Rash—Fluorouracil—head and neck cancer	0.000376	0.00131	CcSEcCtD
Propafenone—Dermatitis—Fluorouracil—head and neck cancer	0.000375	0.00131	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—head and neck cancer	0.000374	0.0013	CcSEcCtD
Propafenone—Headache—Fluorouracil—head and neck cancer	0.000373	0.0013	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000371	0.00129	CcSEcCtD
Propafenone—Fatigue—Docetaxel—head and neck cancer	0.000371	0.00129	CcSEcCtD
Propafenone—Pain—Docetaxel—head and neck cancer	0.000368	0.00128	CcSEcCtD
Propafenone—Constipation—Docetaxel—head and neck cancer	0.000368	0.00128	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—head and neck cancer	0.000354	0.00123	CcSEcCtD
Propafenone—Nausea—Fluorouracil—head and neck cancer	0.000354	0.00123	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000352	0.00122	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—head and neck cancer	0.00034	0.00118	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—head and neck cancer	0.00034	0.00118	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—head and neck cancer	0.000317	0.0011	CcSEcCtD
Propafenone—Asthenia—Docetaxel—head and neck cancer	0.000309	0.00107	CcSEcCtD
Propafenone—Pruritus—Docetaxel—head and neck cancer	0.000304	0.00106	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—head and neck cancer	0.000294	0.00102	CcSEcCtD
Propafenone—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000288	0.0109	CbGpPWpGaD
Propafenone—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000285	0.0108	CbGpPWpGaD
Propafenone—Dizziness—Docetaxel—head and neck cancer	0.000284	0.000989	CcSEcCtD
Propafenone—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000282	0.0107	CbGpPWpGaD
Propafenone—Vomiting—Docetaxel—head and neck cancer	0.000273	0.000951	CcSEcCtD
Propafenone—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000273	0.0103	CbGpPWpGaD
Propafenone—Rash—Docetaxel—head and neck cancer	0.000271	0.000943	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—head and neck cancer	0.000271	0.000942	CcSEcCtD
Propafenone—Headache—Docetaxel—head and neck cancer	0.000269	0.000937	CcSEcCtD
Propafenone—Nausea—Docetaxel—head and neck cancer	0.000255	0.000889	CcSEcCtD
Propafenone—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000251	0.00948	CbGpPWpGaD
Propafenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000247	0.00934	CbGpPWpGaD
Propafenone—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000241	0.00911	CbGpPWpGaD
Propafenone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000232	0.00874	CbGpPWpGaD
Propafenone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000222	0.00839	CbGpPWpGaD
Propafenone—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00022	0.00831	CbGpPWpGaD
Propafenone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000211	0.00796	CbGpPWpGaD
Propafenone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000194	0.00731	CbGpPWpGaD
Propafenone—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000186	0.00704	CbGpPWpGaD
Propafenone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000186	0.00703	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CEBPA—head and neck cancer	0.000184	0.00694	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000175	0.00661	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000173	0.00655	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—MAPK1—head and neck cancer	0.000171	0.00645	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000168	0.00635	CbGpPWpGaD
Propafenone—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000164	0.0062	CbGpPWpGaD
Propafenone—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000164	0.00619	CbGpPWpGaD
Propafenone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00015	0.00566	CbGpPWpGaD
Propafenone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000148	0.00558	CbGpPWpGaD
Propafenone—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000143	0.00538	CbGpPWpGaD
Propafenone—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000141	0.00533	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000139	0.00523	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000138	0.0052	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000136	0.00513	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000129	0.00487	CbGpPWpGaD
Propafenone—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000129	0.00487	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000129	0.00487	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—KISS1—head and neck cancer	0.000128	0.00484	CbGpPWpGaD
Propafenone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000123	0.00465	CbGpPWpGaD
Propafenone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000122	0.0046	CbGpPWpGaD
Propafenone—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000122	0.0046	CbGpPWpGaD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000121	0.00459	CbGpPWpGaD
Propafenone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000121	0.00458	CbGpPWpGaD
Propafenone—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000121	0.00455	CbGpPWpGaD
Propafenone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00012	0.00454	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.00012	0.00454	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.000114	0.00432	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.000114	0.00432	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000113	0.00427	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000112	0.00424	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000112	0.00421	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000111	0.00418	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—GRP—head and neck cancer	0.000106	0.00398	CbGpPWpGaD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000104	0.00394	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000103	0.00389	CbGpPWpGaD
Propafenone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000103	0.00388	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000101	0.00381	CbGpPWpGaD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.97e-05	0.00377	CbGpPWpGaD
Propafenone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.95e-05	0.00376	CbGpPWpGaD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.89e-05	0.00373	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—NAT2—head and neck cancer	9.58e-05	0.00362	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	9.45e-05	0.00357	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	9.19e-05	0.00347	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.62e-05	0.00325	CbGpPWpGaD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.45e-05	0.00319	CbGpPWpGaD
Propafenone—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.39e-05	0.00317	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.35e-05	0.00315	CbGpPWpGaD
Propafenone—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	8.09e-05	0.00306	CbGpPWpGaD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.04e-05	0.00304	CbGpPWpGaD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.94e-05	0.003	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	7.66e-05	0.00289	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	7.64e-05	0.00289	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.4e-05	0.00279	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.3e-05	0.00275	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—KISS1—head and neck cancer	7.24e-05	0.00273	CbGpPWpGaD
Propafenone—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.17e-05	0.00271	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	7.1e-05	0.00268	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	6.81e-05	0.00257	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	6.71e-05	0.00253	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KISS1—head and neck cancer	6.57e-05	0.00248	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.52e-05	0.00246	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	6.45e-05	0.00244	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	6.36e-05	0.0024	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	6.04e-05	0.00228	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—GRP—head and neck cancer	5.96e-05	0.00225	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	5.86e-05	0.00221	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL2—head and neck cancer	5.77e-05	0.00218	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—UROD—head and neck cancer	5.68e-05	0.00214	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	5.67e-05	0.00214	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	5.59e-05	0.00211	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.55e-05	0.00209	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.54e-05	0.00209	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	5.52e-05	0.00208	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.51e-05	0.00208	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.46e-05	0.00206	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.43e-05	0.00205	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.43e-05	0.00205	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.43e-05	0.00205	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—GRP—head and neck cancer	5.41e-05	0.00204	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	5.3e-05	0.002	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	5.25e-05	0.00198	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.22e-05	0.00197	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	5.18e-05	0.00196	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—UROD—head and neck cancer	4.94e-05	0.00187	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	4.91e-05	0.00185	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—VEGFA—head and neck cancer	4.8e-05	0.00181	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	4.73e-05	0.00179	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—MAPK1—head and neck cancer	4.72e-05	0.00178	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	4.67e-05	0.00176	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—UROD—head and neck cancer	4.66e-05	0.00176	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—UROD—head and neck cancer	4.62e-05	0.00174	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MAPK3—head and neck cancer	4.54e-05	0.00172	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	4.49e-05	0.00169	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	4.43e-05	0.00167	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.4e-05	0.00166	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.36e-05	0.00165	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MAPK1—head and neck cancer	4.32e-05	0.00163	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—EGFR—head and neck cancer	4.32e-05	0.00163	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—UROD—head and neck cancer	3.95e-05	0.00149	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KISS1—head and neck cancer	3.88e-05	0.00147	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—HRAS—head and neck cancer	3.79e-05	0.00143	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	3.77e-05	0.00142	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.65e-05	0.00138	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.62e-05	0.00137	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.6e-05	0.00136	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.58e-05	0.00135	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—HRAS—head and neck cancer	3.47e-05	0.00131	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.46e-05	0.00131	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—VEGFA—head and neck cancer	3.43e-05	0.00129	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.42e-05	0.00129	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—STAT3—head and neck cancer	3.39e-05	0.00128	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MAPK3—head and neck cancer	3.24e-05	0.00122	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.24e-05	0.00122	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GRP—head and neck cancer	3.2e-05	0.00121	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT6—head and neck cancer	3.11e-05	0.00117	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MAPK1—head and neck cancer	3.08e-05	0.00116	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—head and neck cancer	3.08e-05	0.00116	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.07e-05	0.00116	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.06e-05	0.00116	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—UROD—head and neck cancer	3.05e-05	0.00115	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.78e-05	0.00105	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—YAP1—head and neck cancer	2.75e-05	0.00104	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.68e-05	0.00101	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.5e-05	0.000945	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.48e-05	0.000936	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—HRAS—head and neck cancer	2.48e-05	0.000935	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.42e-05	0.000914	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NAT2—head and neck cancer	2.36e-05	0.00089	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.29e-05	0.000865	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—AKT1—head and neck cancer	2.19e-05	0.000825	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.18e-05	0.000823	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.18e-05	0.000823	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—DPYD—head and neck cancer	2.07e-05	0.00078	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAT2—head and neck cancer	2.05e-05	0.000775	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.04e-05	0.000769	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.02e-05	0.000761	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—YAP1—head and neck cancer	1.96e-05	0.000741	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAT2—head and neck cancer	1.93e-05	0.000731	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAT2—head and neck cancer	1.92e-05	0.000724	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.89e-05	0.000714	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.83e-05	0.000691	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—DPYD—head and neck cancer	1.8e-05	0.00068	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.74e-05	0.000657	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.72e-05	0.000651	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—YAP1—head and neck cancer	1.71e-05	0.000645	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—DPYD—head and neck cancer	1.7e-05	0.000641	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—DPYD—head and neck cancer	1.68e-05	0.000635	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAT2—head and neck cancer	1.64e-05	0.000619	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—YAP1—head and neck cancer	1.61e-05	0.000608	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—YAP1—head and neck cancer	1.6e-05	0.000603	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—head and neck cancer	1.59e-05	0.0006	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.55e-05	0.000583	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.47e-05	0.000556	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—head and neck cancer	1.44e-05	0.000545	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—DPYD—head and neck cancer	1.44e-05	0.000543	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—YAP1—head and neck cancer	1.36e-05	0.000515	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.29e-05	0.000485	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAT2—head and neck cancer	1.26e-05	0.000478	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH1—head and neck cancer	1.24e-05	0.000468	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.2e-05	0.000453	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMS—head and neck cancer	1.18e-05	0.000445	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.00044	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—head and neck cancer	1.16e-05	0.000438	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—head and neck cancer	1.11e-05	0.000421	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.11e-05	0.000419	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK1—head and neck cancer	1.1e-05	0.000417	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.000417	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—head and neck cancer	1.1e-05	0.000417	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.05e-05	0.000398	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.05e-05	0.000397	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.05e-05	0.000395	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMS—head and neck cancer	1.03e-05	0.000387	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.02e-05	0.000387	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.01e-05	0.000383	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—head and neck cancer	9.71e-06	0.000367	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMS—head and neck cancer	9.67e-06	0.000365	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—head and neck cancer	9.61e-06	0.000363	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMS—head and neck cancer	9.58e-06	0.000362	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—head and neck cancer	9.58e-06	0.000362	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—head and neck cancer	9.56e-06	0.000361	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—head and neck cancer	9.47e-06	0.000358	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—head and neck cancer	9.15e-06	0.000346	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—head and neck cancer	9.07e-06	0.000343	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.07e-06	0.000342	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	9.06e-06	0.000342	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.98e-06	0.000339	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.94e-06	0.000337	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	8.86e-06	0.000335	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	8.62e-06	0.000325	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—head and neck cancer	8.52e-06	0.000322	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—head and neck cancer	8.31e-06	0.000314	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMS—head and neck cancer	8.19e-06	0.000309	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—head and neck cancer	8.1e-06	0.000306	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—head and neck cancer	8.02e-06	0.000303	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	7.82e-06	0.000295	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—head and neck cancer	7.75e-06	0.000293	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—head and neck cancer	7.67e-06	0.00029	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.38e-06	0.000279	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	7.24e-06	0.000274	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—head and neck cancer	7.17e-06	0.000271	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	6.85e-06	0.000259	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.56e-06	0.000248	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	6.52e-06	0.000246	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—head and neck cancer	6.52e-06	0.000246	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMS—head and neck cancer	6.32e-06	0.000239	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.3e-06	0.000238	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.25e-06	0.000236	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—head and neck cancer	5.98e-06	0.000226	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.92e-06	0.000224	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—head and neck cancer	5.72e-06	0.000216	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—head and neck cancer	5.72e-06	0.000216	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	5.66e-06	0.000214	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—head and neck cancer	5.47e-06	0.000207	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.39e-06	0.000203	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.34e-06	0.000202	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—head and neck cancer	5.23e-06	0.000198	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—head and neck cancer	4.99e-06	0.000188	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—head and neck cancer	4.7e-06	0.000177	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—head and neck cancer	4.66e-06	0.000176	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—head and neck cancer	4.62e-06	0.000175	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.56e-06	0.000172	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	4.04e-06	0.000152	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—head and neck cancer	3.98e-06	0.00015	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.52e-06	0.000133	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—head and neck cancer	3.52e-06	0.000133	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.31e-06	0.000125	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—head and neck cancer	3.3e-06	0.000125	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.29e-06	0.000124	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—head and neck cancer	3.07e-06	0.000116	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—head and neck cancer	2.87e-06	0.000108	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.81e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—head and neck cancer	2.71e-06	0.000102	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—head and neck cancer	2.68e-06	0.000101	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—head and neck cancer	2.29e-06	8.66e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.17e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—head and neck cancer	1.77e-06	6.68e-05	CbGpPWpGaD
